Skip to main content
Clinical Trials/NCT03333629
NCT03333629
Completed
Phase 4

Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes

Drexel University3 sites in 1 country2,087 target enrollmentNovember 29, 2017

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Autism Spectrum Disorder
Sponsor
Drexel University
Enrollment
2087
Locations
3
Primary Endpoint
Change in ASD Symptom Severity
Status
Completed
Last Updated
last year

Overview

Brief Summary

Autism spectrum disorder (ASD) is defined by impaired social engagement and social communication, and repetitive, restricted, or stereotyped behaviors and interests. The average age of diagnosis in the US is after the fourth birthday. However, children who start ASD-specific early intervention have better outcomes than children start later. The current study will address a gap identified by the US Prevention Services Task Force, namely that children detected through screening respond positively to early intervention. This study will directly relate early detection strategies to early intervention, and measure the impact of age of intervention onset on outcomes when children are entering kindergarten. Local pediatric providers will be randomized to provide either usual care, or to an experimental condition in which autism early detection strategies are enhanced through the addition of specific procedures. Across all sites, 8,000 children will be recruited through their participating pediatric practice. Qualifying children will receive up to one year of early intensive behavioral intervention, after getting an ASD diagnosis. Primary outcome measures will include children's cognitive functioning and ASD symptom severity, which will be measured at multiple time points. The investigators predict that this study will inform early detection strategies which will result in improving children's social and cognitive functioning, mitigating lifespan disability, reducing societal costs, and improving personal well-being and productivity of individuals with ASD.

Detailed Description

Autism spectrum disorder (ASD) is a serious neurodevelopmental disorder defined by impaired social engagement and social communication, in addition to the presence of repetitive, restricted, or stereotyped behaviors and interests. Although many cases of ASD can be detected when children are less than two years old, the average age of diagnosis in the US is still after the fourth birthday. However, evidence demonstrates that children who start ASD-specific early intervention have better outcomes than children who do not start treatment until later ages. In 2006 and 2007, American Academy of Pediatrics recommended three early detection approaches to improve identification of children at risk for ASD: ongoing developmental surveillance at every well-child check-up, routine broad developmental screening at three infant/toddler ages, and ASD-specific screening at two toddler ages. When these early detection strategies are used with all children attending well-child check-ups, the age of ASD detection is lower, and children who are diagnosed have the opportunity to start ASD-specific early intervention at younger ages than if they had not been detected. Yet in 2016, the US Preventive Services Task Force (USPSTF) indicated that current evidence is insufficient to recommend universal ASD screening, given the lack of experimental studies demonstrating positive outcomes for treated children that are detected through screening. The current study will address this gap. This study will directly relate early detection strategies to early intervention, and measure the impact of age of intervention onset on outcomes when children are entering kindergarten. The study will be conducted by investigators from three sites: Drexel University; the University of California, Davis; and the University of Connecticut. Local pediatric providers will be enrolled in the study, and their practices will be randomized to provide either usual care, or to an experimental condition in which autism early detection strategies are enhanced through the addition of specific procedures. Children attending well-child visits at participating practices will then be enrolled. Across all sites, 8,000 children will be recruited through their participating pediatric practice. As part of the study, qualifying children will receive up to one year of early intensive behavioral intervention, using an evidence-based manualized treatment. Primary outcome measures will include children's cognitive functioning and ASD symptom severity, which will be measured at multiple time points. Exploratory outcomes will include children's adaptive functioning, kindergarten readiness, and social reciprocity, as measured by experimental eye tracking and parent-child interaction ratings. This study also will examine the impact of the screening intervention on physician attitudes and on parent empowerment and stress. Finally, investigators will examine potential moderators of outcomes, to determine whether initial symptom severity, cognitive ability, or socioeconomic status affects children's long-term outcomes. The investigators predict that this study will inform early detection strategies which will result in improving children's social and cognitive functioning, mitigating lifespan disability, reducing societal costs, and improving personal well-being and productivity of individuals with ASD.

Registry
clinicaltrials.gov
Start Date
November 29, 2017
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Diana Robins

Professor

Drexel University

Eligibility Criteria

Inclusion Criteria

  • child attended 18 m visiting at participating pediatric practice
  • legal guardian is fluent in English or Spanish

Exclusion Criteria

  • child has severe sensory or motor deficit that precludes completing standardized evaluation

Outcomes

Primary Outcomes

Change in ASD Symptom Severity

Time Frame: Change from pre-treatment to immediately post-treatment; 10 minutes

ASD symptom severity will be measured with the Brief Observation of Social Communication Change (BOSCC)

Change in Cognitive Functioning

Time Frame: Change from pre-treatment to immediately post-treatment; 60 minutes

Cognitive functioning will be measured by the Mullen Scales of Early Learning (MSEL).

Secondary Outcomes

  • ASD symptoms - secondary measure2(Immediately post-treatment, 48 m, 60 m; 20 minutes)
  • ASD symptoms - secondary measure3(48 m, 60 m; 10 minutes)
  • Long-term change in Cognitive Functioning (alternative)(48 m, 60 m; 60 minutes)
  • ASD Symptoms - secondary measure1(48 m, 60 m; 45 minutes)
  • Social Engagement(Immediately post-treatment, 48 m, 60 m; 15 minutes)
  • Long-term change in Cognitive Functioning(48 m, 60 m; 60 minutes)
  • Parent-Child Social Engagement(Immediately post-treatment, 48 m, 60 m; 15 minutes)
  • Adaptive Functioning(Immediately post-treatment, 48 m, 60 m; 45 minutes)
  • Kindergarten Readiness(60 m; 45 minutes)

Study Sites (3)

Loading locations...

Similar Trials